Results 131 to 140 of about 3,215 (244)

Organ‐Specific Human Microbiomes and Dysbiosis: Mechanistic Links to Disease and Emerging Therapeutic Strategies

open access: yesJournal of Clinical Laboratory Analysis, EarlyView.
Schematic overview of the human microbiome and major microbiota‐derived metabolites across body sites, highlighting the gut–brain, gut–heart, and gut–kidney axes in host physiology and disease. ABSTRACT Background The human microbiome is a dynamic and diverse community of microorganisms that affects susceptibility to illness and promotes wellness ...
Awadh Alanazi
wiley   +1 more source

Gut microbiome in pediatric acute pancreatitis and Crohn's disease versus irritable bowel syndrome and healthy controls

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Pediatric acute pancreatitis (AP), Crohn's disease (CD), and irritable bowel syndrome (IBS) are associated with gut dysbiosis, but differences and similarities between conditions are unknown. We hypothesized that gut microbial ecology would differ across these disorders. Methods Stool was collected from 120 subjects (AP [n = 30], CD
Neha R. Santucci   +9 more
wiley   +1 more source

Glutamine and partially hydrolyzed guar gum promote intestinal adaptation and modulate small intestinal microbiota in high‐output stoma: A case report

open access: yesJPGN Reports, EarlyView.
Abstract We report a case of a very low‐birth‐weight infant with a high‐output stoma following necrotizing enterocolitis. The patient exhibited villous atrophy and microbial dysbiosis. Supplementation with glutamine and partially hydrolyzed guar gum (PHGG) was initiated, leading to reduced stoma output, improved feeding tolerance, and appropriate ...
Yunosuke Kawaguchi   +12 more
wiley   +1 more source

Polyvinyl Butyrate Nanoparticles as Butyrate Donors for Colitis Treatment

open access: yesPolyvinyl Butyrate Nanoparticles as Butyrate Donors for Colitis Treatment
Butyrate has been attracting attention for the suppression of inflammatory bowel disease (IBD). However, clinical trials of butyrate for IBD treatment have resulted in controversial outcomes, likely owing to the adverse effect of butyrate on the intestinal epithelium that was observed at high butyrate concentrations.
openaire  

Gut microbiota and fecal 2-methylbutyric acid in coronary heart disease: a cross-sectional study. [PDF]

open access: yesSci Rep
Dechkhajorn W   +5 more
europepmc   +1 more source

Advantages of low‐glycaemic‐index carbohydrates in regulating glycaemic response of energy bar: A review

open access: yesJournal of the Science of Food and Agriculture, EarlyView.
Abstract Energy bars are widely consumed functional foods among athletes and physically active consumers who require convenient sources of sustained energy. Their carbohydrate composition, particularly the type and ratio of digestible sugars such as glucose, fructose and sucrose, strongly influences glycaemic index (GI), postprandial blood glucose ...
Raju Sasikumar   +8 more
wiley   +1 more source

Preventive Effect of Butyrate in Colon Cancer Cell Metabolism. [PDF]

open access: yesInt J Mol Sci
Gonçalves TJ   +8 more
europepmc   +1 more source

Copaiba oleoresin as a substitute for sodium lasalocid in high‐concentrate diets for lambs: growth performance, ingestive behavior, and metabolic and ruminal parameters

open access: yesJournal of the Science of Food and Agriculture, EarlyView.
Abstract BACKGROUND The indiscriminate and excessive use of ionophore additives has been associated with the emergence of multi‐resistant pathogenic strains and the global spread of antibiotic resistance, raising serious public health concerns. Thus, plant biocompounds have been the focus of several studies aiming to replace ionophore additives in ...
Jéssica Carvalho de Pantoja   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy